Open-Label Extension Study to Assess the Safety and Seizure Frequency Associated With Lacosamide for Primary Generalized Tonic-Clonic Seizures in Subjects With Epilepsy - Trial 2014-004375-23
Access comprehensive clinical trial information for 2014-004375-23 through Pure Global AI's free database. This phase not specified trial is sponsored by UCB BIOSCIENCES, Inc. and is currently status unknown. The study focuses on Epilepsy.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
2014-004375-23
Trial Details
EU Clinical Trials Register • 2014-004375-23
Open-Label Extension Study to Assess the Safety and Seizure Frequency Associated With Lacosamide for Primary Generalized Tonic-Clonic Seizures in Subjects With Epilepsy
Study Focus
Sponsor & Location
UCB BIOSCIENCES, Inc.
Timeline & Enrollment
N/A
N/A
N/A
Primary Outcome
- Subject meets the withdrawal criteria for SP0961 (2014-004379-22) or is experiencing an ongoing Serious Adverse Event (SAE)
ICD-10 Classifications
Epilepsy
Epilepsy, unspecified
Other epilepsy
Status epilepticus
Other status epilepticus
Data Source
EU Clinical Trials Register
2014-004375-23
Non-Device Trial